Eufoton, an Italian laser maker, cleared its LASEmaR 1500 — a diode laser in the class used for vascular lesions and soft-tissue procedures.
For an aesthetic owner, the relevance is all about your menu. If you treat vascular concerns or do laser-assisted procedures, another cleared diode platform widens your buying options and your leverage on price and service terms. If your book is mostly tox, filler, and facials, this is a quick skim and move on.
The pattern underneath it is the useful part. A steady drip of mid-tier European and Asian laser makers clearing U.S. devices means the laser market keeps getting more competitive — good for buyers, and rough on anyone who signed a five-year lease on a single-source platform last year. Keep it in mind before your next big capital commitment.
Confirm the specific cleared indications in the FDA record before assuming it fits your use.
View the official FDA record ↗
This post summarizes a public FDA database entry for medical-aesthetics owners. It is general business information, not medical, legal, or regulatory advice. Always confirm scope, lot numbers, and classification against the official FDA record, and consult your own clinician or counsel for anything clinical or compliance-related.